We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$584M
AUM Growth
-$30.8M
Cap. Flow
-$1.84M
Cap. Flow %
-0.32%
Top 10 Hldgs %
24.56%
Holding
490
New
13
Increased
6
Reduced
11
Closed
13

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$695K
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$627K
3
SNY icon
Sanofi
SNY
+$579K
4
XOM icon
ExxonMobil
XOM
+$566K
5
VERV
Verve Therapeutics
VERV
+$447K

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$1.44M
2
COHR
Coherent Inc
COHR
+$1.33M
3
CVX icon
Chevron
CVX
+$549K
4
TMUS icon
T-Mobile US
TMUS
+$548K
5
LOW icon
Lowe's Companies
LOW
+$545K

Sector Composition

Rank Sector Weight
1 Technology 24.39%
2 Healthcare 14.9%
3 Financials 13.21%
4 Industrials 11.84%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$38.3M 6.57%
277,400
– –
MSFT icon
2
Microsoft
MSFT
$3.45T
$31.3M 5.36%
134,300
– –
AMZN icon
3
Amazon
AMZN
$2.92T
$16.5M 2.82%
145,800
– –
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$12.3M 2.1%
127,700
– –
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$8.98M 1.54%
55,000
– –
LLY icon
6
Eli Lilly
LLY
$1.02T
$8.49M 1.46%
26,260
– –
JPM icon
7
JPMorgan Chase
JPM
$935B
$8.2M 1.41%
78,500
– –
MRK icon
8
Merck
MRK
$322B
$6.91M 1.18%
80,252
– –
XOM icon
9
ExxonMobil
XOM
$644B
$6.57M 1.13%
75,200
+6,200
+9% +$566K
PG icon
10
Procter & Gamble
PG
$336B
$5.77M 0.99%
45,700
– –
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.36T
$5.51M 0.94%
57,600
– –
AMT icon
12
American Tower
AMT
$80.8B
$5.41M 0.93%
25,200
– –
WMT icon
13
Walmart Inc
WMT
$885B
$5.19M 0.89%
120,000
– –
AXP icon
14
American Express
AXP
$227B
$4.87M 0.83%
36,100
– –
META icon
15
Meta Platforms (Facebook)
META
$1.42T
$4.79M 0.82%
35,300
– –
KLAC icon
16
KLA
KLAC
$239B
$4.54M 0.78%
150,000
– –
CVX icon
17
Chevron
CVX
$392B
$4.51M 0.77%
31,400
-3,600
-10% -$549K
UNP icon
18
Union Pacific
UNP
$174B
$4.29M 0.73%
22,000
-6,500
-23% -$1.44M
CVS icon
19
CVS Health
CVS
$133B
$4.17M 0.72%
43,766
– –
ORCL icon
20
Oracle
ORCL
$374B
$4.09M 0.7%
67,000
– –
MRSH
21
Marsh
MRSH
$90.5B
$4.03M 0.69%
27,000
– –
GS icon
22
Goldman Sachs
GS
$300B
$3.97M 0.68%
13,550
– –
COST icon
23
Costco
COST
$422B
$3.97M 0.68%
8,400
– –
CSCO icon
24
Cisco
CSCO
$457B
$3.88M 0.66%
97,000
– –
MCD icon
25
McDonald's
MCD
$192B
$3.81M 0.65%
16,493
– –
1
2 3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2022 Portfolio in Review

As of Q3 2022, NJ State Employees Deferred Compensation Plan held 490 positions worth $584M, down 5% from $614M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2022 filing shows 13 new, 6 increased, 11 reduced and 13 closed positions. Its largest new stake was Sarepta Therapeutics: 6,900 shares worth $763K. The largest sale was Union Pacific, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2022 buy was Sarepta Therapeutics: 6,900 shares worth $763K.
  • NJ State Employees Deferred Compensation Plan added most to ExxonMobil in Q3 2022, an estimated $566K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2022 reduction was Union Pacific, cutting an estimated $1.44M.
  • NJ State Employees Deferred Compensation Plan fully exited Coherent Inc in Q3 2022, selling an estimated $1.33M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $584M portfolio in Q3 2022.
  • NJ State Employees Deferred Compensation Plan opened 13 new positions and closed 13 in Q3 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 5% quarter-over-quarter to $584M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2022, filed 28 Oct 2022.